The human serine/threonine kinase Aurora-B is structurally related to the protein kinase Ipl1p from S cerevisiae and aurora from Drosophila melanogaster, which are key regulators of mitosis. The present study shows that human Aurora-B is activated by okadaic acid and forms complexes with the protein serine/threonine phosphatase type 1 (PP1) or PP2A, but not with PP5. These data identi®ed Aurora-B associated protein phosphatases as negative regulators of kinase activation. We then used a series of substrates based on a histone H3 phosphorylation site (residues 5 ± 15) to determine the substrate speci®city of human Aurora-B. We found that this enzyme is an arginine-directed kinase that can phosphorylate histone H3 at serines 10 and 28 in vitro, suggesting that human Aurora-B is a mitotic histone H3 kinase.
Introduction
The two post-translational mechanisms, proteolysis and reversible protein phosphorylation, play major roles in the regulation of centrosome separation, chromosome segregation and cytokinesis (Zachariae and Nasmyth, 1999) . The proteolytic machinery is intimately regulated by phosphorylation, whereas it is responsible for the destruction of mitotic cyclins and several mitotic kinases. The most studied kinase of M phase progression is cyclin-dependent kinase 1 (Cdk1). In addition to Cdk1, the polo-like kinases, as well as the NimA-related (NEK), Bub1, LATS and Aurora families are implicated in a variety of mitotic processes (Nigg, 2001 ).
The ®rst members of the Aurora family to be identi®ed were budding yeast Ipl1p and Drosophila aurora, which are required for chromosome segregation, centrosome maturation and function of the mitotic spindle; they constitute a family of serine/ threonine kinases (Francisco et al., 1994; Glover et al., 1995) . Three genes in human and mouse, two each in the¯y, frog and worm, and one in budding yeast, encode members of the Aurora family. Human Aurora-1/AIRK2/ARK2/Aik2/STK-12, mouse STK-1, and rat AIM-1 appear to constitute a subfamily, because these protein kinases have closely related Nas well as C-terminal kinase domains. Herein we refer to these proteins as Aurora-B according to the recommended nomenclature Nigg, 2001) . The message and protein levels of Aurora-B are cell-cycle regulated (Bischo et al., 1998; Terada et al., 1998) . Aurora-B localizes at centromeres until metaphase, then transfers to the central spindle during anaphase, and ®nally accumulates at the spindle midbody during telophase and cytokinesis (Adams et al., 2000; Terada et al., 1998) . Aurora-B overexpression may contribute to the malignant phenotype of some colorectal carcinomas. .
Covalent modi®cations on histone tails, including acetylation, phosphorylation, methylation and in combinations, have been characterized (Jenuwein and Allis, 2001; Strahl and Allis, 2000) . Histone H3 phosphorylation is mediated by RSK2, MSK1 and mitogen-activated protein kinases depending on the speci®c stimulation or stress, and thereby induces immediate-early gene expression (Sassone-Corsi et al., 1999; Thomson et al., 1999; Zhong et al., 2001) . Mitotic chromosome condensation is also closely linked with histone H3 phosphorylation at serines 10 and 28 (Goto et al., 1999; Hendzel et al., 1997; Wei et al., 1999) , and several mitosis-speci®c serine 10 kinases have been identi®ed, including NimA in A nidulans (De Souza et al., 2000) and Aurora-B in S cerevisiae, C elegans (Hsu et al., 2000) , and Xenopus (Murnion et al., 2001) .
In opposition to the kinases, mitotic histone H3 phosphorylation is also regulated by at least one PP1.
Genetic suppressors of the temperature-sensitive ipl-1 in S cerevisiae include speci®c alleles of glc7, a gene that encodes that catalytic subunit of PP1 (PP1c) (Francisco et al., 1994) . In S cerevisiae, C elegans and Xenopus, reduction of PP1 activity partially suppresses defects in the mitotic histone H3 phosphorylation (Giet and Glover, 2001; Hsu et al., 2000; Murnion et al., 2001; Speliotes et al., 2000) . These studies suggest that a balance of kinase and phosphatase activities regulates the mitotic phosphorylation of histone H3 but do not exclude the possibility that these enzymes regulate each other. In mammals, three genes encode four isoforms of PP1c (PP1a, PP1d, PP1g1 and PP1g2) (Sasaki et al., 1990) . The isoforms of PP1c have distinct subcellular localizations. During mitosis, PP-1a is localized to the centrosome, PP-1g1 is associated with microtubules of the mitotic spindle, and PP-1d associates with chromosomes (Andreassen et al., 1998) .
The present study shows that human Aurora-B is activated by okadaic acid and forms kinase-phosphatase complexes with PP1 or PP2A. We found that human Aurora-A is an arginine-directed kinase, using a series of substrates based on a histone H3 phosphorylation site (residues 5 ± 15). We also demonstrated that human Aurora-B can phosphorylate histone H3 at serines 10 and 28 in vitro.
Results

Dose-dependent effect of okadaic acid upon Aurora-B activation
Okadaic acid is a potent inhibitor of PP1, PP2A and PP5 (Cohen, 1997) . Since okadaic acid activates Xenopus Aurora-A/Eg2 (Andresson and Ruderman, 1998) and human Aurora-A (Walter et al., 2000) , phosphorylation might be involved in regulation of the kinase activity of the Aurora family. To investigate whether okadaic acid aects human Aurora-B activity, we incubated transfected COS cells with various concentrations of okadaic acid and performed in vitro kinase assays with glu-Aurora-B immunoprecipitates and GST-H3 (5 ± 15) as the substrate. Histone H3 is a putative in vivo substrate for Aurora-B (Hsu et al., 2000) . We found that okadaic acid increased Aurora-B kinase activity in a dose-dependent manner (Figure 1a) , while the expression level of Aurora-B did not signi®cantly change. Control immunoprecipitates derived from okadaic acid treated COS cells transfected with an empty expression vector had no GST-H3 (5 ± 15) kinase activity ( Figure 1a , lane 6). Aurora-B was activated within 30 min in the presence of 0.4 mM okadaic acid. In addition, okadaic acid (0.4 mM) did not cause a substantial increase in the percentage of cells in G2/M (data not shown), indicating that the Aurora-B activation induced by okadaic acid was not associated with G2/M accumulation. These results suggested that Aurora-B must be phosphorylated to exert its activity in vivo. Importantly, more than 0.1 mM of okadaic acid was required to aect Aurora-B activity. Okadaic acid inhibits all PP1, PP2A and PP5 activities at a concentration of 0.4 mM, while at lower concentrations only PP2A and PP5 are inhibited (Chinkers, 2001; Hardie et al., 1991) .
To elucidate the speci®city of histone H3 phosphorylation by Aurora-B exposed to okadaic acid, we prepared a catalytically inactivate mutant of human Aurora-B, in which is a critical lysine residue (K106) has been replaced with arginine in the ATP-binding motif of the catalytic domain (Hanks and Hunter, 1995) . In contrast to wild-type, the mutant form of Aurora-B displayed no kinase activity to substrate GST-H3 (5 ± 15) (Figure 1b, compare lanes 2 and 4) . Therefore, the mutant of this invariant lysine residue within the catalytic domain of Aurora-B is the catalytically inactive form, and GST-H3 (5 ± 15) is an appropriate substrate for Aurora-B. We noted that gluimmunoprecipitated Aurora-B was phosphorylated in the absence of okadaic acid when GST-H3 (5 ± 15) was not phosphorylated and that Aurora-B phosphorylation was further increased by increasing concentrations of okadaic acid ( Figure 1a) . Aurora-B is expressed at the G2/M phase of the cell cycle (Bischo et al., 1998; Terada et al., 1998) . To determine whether or not the microtubule-depolymerizing drug nocodazole in¯uences Aurora-B activity, we transfected glu-Aurora-B into COS cells, then incubated them with nocodazole for harvesting at M phase. In vitro kinase assays were performed using gluAurora-B immunoprecipitates and GST-H3 (5 ± 15) as substrate. In contrast to the eect of okadaic acid, Aurora-B was not activated by nocodazole (Figure 1c ). This ®nding con®rmed the importance of the okadaic acid-sensitive phosphatase(s) in Aurora-B activation and demonstrated that M phase arrested by nocodazole is not sucient to activate Aurora-B.
Aurora-B interacts with PP1 and PP2A, but not with PP5
Okadaic acid speci®cally activated Aurora-B, which contained one stretch ( 106 KVLF) that was similar to the consensus motif for binding to PP1c (Figure 2c ). We therefore examined whether PP1 associated physically with Aurora-B. PP1g1 were detected in Aurora-B immunoprecipitates prepared from exponentially growing HeLa cells. PP1g1 could not be detected in immunoprecipitates prepared with control anti-glu monoclonal antibody (Figure 2a ), demonstrating the speci®city of the interaction. We then veri®ed the interaction between Aurora-B and PP1c in COS cells transfected with three PP1c isoforms (myc-tagged) either alone or together with glu-Aurora-B. GluAurora-B immunoprecipitates contained all three PP1c isoforms ( Figure 2b , lanes 5 to 7). On the other hand, anti-glu immunoprecipitates from cells transfected with myc-tagged PP1c alone did not contain any PP1c isoforms ( Figure 2b , lanes 1 to 3). To determine whether the interaction was dependent upon the short consensus sequence for binding to PP1c, the aromatic residue (phenylalanine 109) conserved in this motif was mutated to alanine (FA mutant; Figure 2c ) (Bollen, 2001 ). We introduced glu-Aurora-B (FA) cDNA into COS cells with myc-tagged PP1g1. The amount of PP1g1 binding to Aurora-B and to Aurora-B (FA) did not signi®cantly dier ( Figure 2d , lanes 3 versus 6). To assess interactions between Aurora-B and okadaic acid-sensitive PP2A or PP5, we monitored the presence of myc-tagged PP2Ac or PP5 in anti-glu immunoprecipitates from cells overexpressing glu-Aurora-B with myc-tagged PPs. We detected PP2Ac in glu-Aurora-B immunoprecipitates ( Figure 2d , lane 8), but not PP5 (Figure 2d , lane 10). We then tested whether endogenous PP2Ac forms complex with Aurora-B. We transfected expression plasmids for GST or GSTAurora-B alone into COS cells. GST or GST-Aurora-B was pulled down using glutathione-Sepharose beads, and the complexes were assayed by immunoblots. We detected endogenous PP2Ac in GST-Aurora-B complex, but not in GST complex (Figure 2e ). The results of using glu-immunoprecipitated Aurora-B and endogenous PP2Ac were similar (data not shown). Therefore, interactions between Aurora-B and PP1c or PP2Ac are speci®c, and the association between Aurora-B and PP1c is independent of the consensus motif for binding to PP1c. The binding site(s) in Aurora-B to PP1c and PP2Ac is currently unknown but remains to be elucidated in future studies.
We next examined whether okadaic acid in¯uences the association between Aurora-B and PP1c. Figure 2f shows that okadaic acid had no apparent eect on the binding between Aurora-B and PP1g1. The results of using glu-immunoprecipitated Aurora-B and PP1a were similar (data not shown).
To investigate the role of PP1 and PP2A in regulation of Aurora-B activity, we examined whether PP1 or PP2A aects Aurora-B activity. Glu-Aurora-B immunoprecipitates from COS cells treated by okadaic acid were incubated with puri®ed PP1 and PP2A, respectively, and in vitro kinase assays were subsequently performed with microcystin. Both PP1 and PP2A inactivated Aurora-B in a dose-dependent manner (Figure 2g ).
Aurora-B is an arginine-directed kinase
Histone H3 is a putative in vivo substrate for Aurora-B (Hsu et al., 2000) , but the amino acid sequences surrounding the phosphorylation site of this histone H3 have not been described. To characterize the Glu-tagged Aurora-B was transiently expressed in COS cells. Transfected cells were incubated for 30 min in either the absence (7) or presence (+) of 0.4 mM okadaic acid (OA). COS cells were also incubated with 400 ng/ml nocodazole for 14 h before preparation Glu-Aurora-B was immunoprecipitated using a mouse anti-glu monoclonal antibody, and immunocomplexes were assayed by in vitro kinase assays. After termination, reaction mixtures were resolved by SDS-polyacrylamide gel electrophoresis and visualized by autoradiography (left panels). Coomassie Brilliant Blue R-250 staining (right panels) shows equal amounts of immunoprecipitated Aurora-B and recombinant GST fusion proteins containing an H3 amino terminus (residues 5 ± 15) as substrate. All data from in vitro kinase assays are representative of multiple independent studies. Positions of molecular mass standards are indicated on the left of each panel. Asterisk denotes position of immunoglobulin and PP2A, respectively, and in vitro kinase assays were subsequently performed substrate speci®city requirements of human Aurora-B, we constructed a series of substrates based on the histone H3 phosphorylation site (residues 5 ± 15), and attached them to the carboxyl terminus of GST via gene fusion, as summarized in Figure 3a . We then tested their ability to act as substrates for Aurora-B in vitro. A phosphorylation site mutant S10A (in which serine 10 was changed to alanine) was not essentially phosphorylated by Aurora-B (Figure 3b, lane 7) . This is consistent with the reported ®nding that serine 10 of histone H3 is a target for Aurora-B. The phosphorylation eciency of Aurora-B for K9A, T11A and K14A was about 20, 20 and 50% of the wild type, respectively. When R8A (arginine 8 to alanine substitution) was the substrate, phosphate was not incorporated (Figure 3b, lane 3) . We changed the arginine residue at the 72 position to lysine. This manipulation signi®cantly reduced the phosphorylation eciency of Aurora-B (Figure 3b, lane 4) , demonstrating a strict requirement for arginine (and not simply any basic residue) at the 72 position.
To con®rm that the kinase activity is an intrinsic property of Aurora-B, we repeated the in vitro kinase assay using recombinant Aurora-B. Figure 3c shows that recombinant Aurora-B phosphorylated GST-H3 (5 ± 15). Furthermore, the relative phosphorylation eciency of glu-Aurora-B produced in mammalian cells and of his-Aurora-B produced in E coli for the substrates was comparable, with the exception of K9A. Therefore, we concluded that Aurora-B preferentially phosphorylates when arginine is located two residues upstream of the phosphoserine (the 72 position) and that other residues between the 72 and +4 positions also in¯uence phosphorylation eciency.
Serine 28 of histone H3 phosphorylated by Aurora-B in vitro
We examined whether or not Aurora-B phosphorylates full-length histone H3 in vitro. Figure 4a shows that recombinant full-length histone H3 was phosphorylated by Aurora-B. We also performed the in vitro kinase assay using puri®ed native histone H3 as the substrate. Aurora-B phosphorylated signi®cantly more native H3 than recombinant H3 (data not shown). To con®rm that serine 10 is a phosphorylation site, we introduced a serine 10 to alanine substitution into fulllength histone H3 (mutant S10A). Aurora-B phosphorylated this mutant, but at 30% of the eciency at which it phosphorylated the wild-type (Figure 4a ). This suggested that Aurora-B can phosphorylate two or more serine/threonine sites in histone H3.
Serines 10 and 28 in histone H3 are in vivo phosphorylation sites (Goto et al., 1999) . We noted that serine 10 and serine 28 of histone H3 have identical surrounding sequences (ARKS; Figure 4b ). To determine the role of Aurora-B in mediating H3 phosphorylation at serines 10 and 28, we incubated recombinant full-length histone H3 with Aurora-B in the presence or absence of 200 mM ATP and detected phosphorylated H3 at serines 10 and 28 using speci®c polyclonal antibodies. The results show that recombinant full-length histone H3 at serines 10 and 28 was phosphorylated by Aurora-B in vitro (Figure 4c) . The a b c Figure 3 Substrate speci®city of human Aurora-B. (a) Schematic diagram of sequences of recombinant GST fusion histone H3 amino terminus (residues 5 ± 15), GST-H3 (5 ± 15), and mutants used as substrates. Box labeled GST denotes GST moiety. Position of serine 10 in histone H3 is shown on the top. Highlighted letters represent mutated amino acids. (b) COS-7 cells were transfected with expression plasmids (1 mg) for glu-Aurora-B. Transfected cells incubated with okadaic acid for 30 min prior to lysis. GST fusion proteins listed in a were puri®ed and incubated with glu-Aurora-B immunoprecipitates in this in vitro kinase assay. (c) Recombinant his-tagged Aurora-B carboxyl terminus (residues 61 ± 344), Aurora-B (DN), was the kinase in this in vitro kinase assay. Samples were separated on a polyacrylamide gel, stained, dried, and exposed. The autoradiograph in the upper panel shows phosphorylated GST fusion protein, whereas the Coomassie staining in the middle and lower panels shows the total amounts of GST fusion protein and kinase, respectively. Asterisk indicates position of immunoglobulin results obtained using glu-immunoprecipitated Aurora-B as the kinase were similar (data not shown). One residue downstream of the phosphoserine 28 (the +1 position) is alanine. Figure 3b and c show that serine 10 phosphorylation was signi®cantly reduced when threonine at the +1 position of the phosphorylated serine 10 was substituted with alanine. Thus, we estimated whether GST-H3 (23 ± 33) and GST-H3 (5 ± 15) are comparably phosphorylated by Aurora-B. The phosphorylation eciency of Aurora-B for GST-H3 (23 ± 33) was about 15% of that for GST-H3 (5 ± 15) (Figure 4d, compare lanes 2 and 3) . In contrast, S28A was not phosphorylated by Aurora-B (Figure 4d, lane 4) . Aurora-B preferred GST-H3 (5 ± 15) over , but it could phosphorylate serine 28 in histone H3. These results suggested that Aurora-B is the mitotic kinase of serines 10 and 28 in histone H3 in vivo, but our results do not exclude the possibility that a related kinase is responsible for the mitotic phosphorylation of histone H3.
Discussion
The reversible phosphorylation of proteins plays a major role in eukaryotic cell cycle progression. Therefore, the complex mechanisms controlling the activity of the cellular kinases and phosphatases that participate in the control of cell cycle progression need to be determined for understanding both normal and oncogenic cellular proliferation. The present study showed that the protein serine/threonine kinase, Aurora-B, which regulates mitotic H3 phosphorylation under normal chromosome dynamics (Hsu et al., 2000) and cytokinesis , is activated by okadaic acid and forms complexes with PP1 or PP2A. Several kinase-phosphatase complexes modulate cellular signals, such as centrosomal kinase Nek2-PP1 (Helps et al., 2000) and calmodulin kinase IV-PP2A (Westphal et al., 1998) . The targeting of complexes containing protein kinase and phosphatase to a speci®c substrate and their tight regulation can explain how kinases can be transiently activated in response to an upstream signal and yet rapidly down-regulated. Alternatively, kinase-phosphatase complexes may cause the ordered addition and removal of phosphate from substrates. Mammalian Aurora-B localizes to centromeres until metaphase, but subsequently transfers to the microtubule midzone during anaphase, then ®nally accumulates at the spindle midbody during telophase and cytokinesis (data not shown) (Adams et al., 2000; Terada et al., 1998) . We demonstrated that at least three distinct isoforms of PP1c (PP1a, PP1d and PP1g1) can interact with Aurora-B. PP1d associates with chromosomes during mitosis (Andreassen et al., 1998) , suggesting that PP1d is a physiological binding partner. PP1g1 associates with microtubules of the mitotic spindle (Andreassen et al., 1998) , but the inhibition of its expression leads to the formation of dikaryons following the failure of cytokinesis (Cheng et al., 2000) . This phenotype is very similar to that induced by the overexpression of kinase-inactivate Aurora-B . To re-examine the localization of PP1g1, expression constructs of PP1g1 fused with EGFP were introduced into mammalian cells, and the fate of transiently expressed proteins in mitotic cells was observed. EGFP-PP1g1 was localized in the centromeric regions in metaphase chromosomes, but most of it was located in the cytoplasm (data not shown). The activity of PP1c is down-regulated by the cell-cycle dependent phosphorylation of serine/threonine residues in its carboxyl terminus by Cdk1 and Nek2 (Helps et al., 2000; Kwon et al., 1997) . Several protein kinases are substrates for PP2A, and PP2A appears to be the major kinase phosphatase in eukaryotic cells that downregulates activated protein kinases (Millward et al., 1999) . Details of the relationship between Aurora-B and PPs, including the binding site, remain to be explored.
Upstream regulators of Aurora-B remain unknown. Wild-type and catalytically inactive forms of Aurora-B were phosphorylated without okadaic acid (Figure 1b,  lanes 1 and 3) . This data suggests that Aurora-B is associated with unidenti®ed kinase(s) which can phosphorylate Aurora-B. Unidenti®ed kinase(s) was also activated by okadaic acid (Figure 1b, lanes 3  versus 4) , but the activated kinase(s) could not phosphorylate GST-H3 (5 ± 15) directly (Figure 1b , lane 4). This associated kinase(s) is a potential upstream kinase. Now we have started to purify the kinase(s) associated with Aurora-B.
Alanine-scanning analysis of the amino acid sequences surrounding the phosphorylation site of histone H3 demonstrated that Aurora-B is an arginine-directed kinase. The requirement for an arginine residue at position 72 is stringent, because substituting the residue with lysine or alanine signi®cantly decreased phosphorylation. This motif resembled the consensus sequence for cyclic AMPdependent protein kinase (cAPK) (Kennelly and Krebs, 1991) . In support of this view, Aurora-B contains the acidic residue glutamate at position 256 within the kinase domain which, based on homology to cAPK (Bossemeyer et al., 1993; Zheng et al., 1993) , suggests a requirement for arginine residue at position 72 in the target sequence. However, to understand the structural and functional relationships between Aurora-B and its substrate(s), the crystal structure of the kinase-peptide substrate complex should be resolved. Identi®cation of the consensus sequence for phosphorylation by Aurora-B may prove useful in pinpointing other physiological targets of Aurora-B.
Materials and methods
Materials
Polyclonal antibodies speci®c to phosphorylated serines 10 or 28 in histone H3 were obtained from Cell Signaling Technology. Anti-GST monoclonal antibody was obtained from Amersham Biosciences. Anti-glu and anti-myc monoclonal antibodies were gifts from Dr Larry A Feig (Tufts University, Boston, MA, USA). Polyclonal antibodies speci®c to PP1c isoforms and PP2Ac have been described (Ishizaka et al., 1992; Shima et al., 1993) . Anti-Aurora-B monoclonal antibody (H7-4) will be described elsewhere (manuscripts in preparation).
Plasmid constructs
We obtained cDNAs of human Aurora-B, histone H3.3 and the catalytic subunits of protein phosphatases by reverse transcription-polymerase chain reaction (PCR) using total RNA from DLD-1 colon cancer cells. Aurora-B (DN) is an N-terminal deletion mutant (amino acids 1 ± 60) of Aurora-B. To create a mammalian expression vector, cDNA was inserted into an altered version of pMT3 that contained a modi®ed glu (MEFMPME) 5' in the cloning site (Urano et al., 1996) . Mammalian GST expression plasmid pME-Gex4T-1 (kindly provided by Dr Tadashi Yamamoto, Tokyo) was modi®ed to contain BglII site in place of BamHI in the multiple cloning site of pGEX4T-2 (Amersham Biosciences). Hereafter we refer to this altered version of pME-Gex4T-1 as pME4T-2. For expression of GST fusion protein in COS-7 cells, cDNA was inserted into pME4T-2. Catalytic subunits of protein phosphatases were introduced into the myc/ pcDNA3 mammalian expression vector (Invitrogen). Point mutations within Aurora-B and the amino terminus of histone H3.3 were engineered by standard double PCR mutagenesis. All PCR-ampli®ed cDNA products were con®rmed by sequencing. The short fragments (residues 5 ± 15 or 23 ± 33) of human histone H3 used as substrates were cloned into pGEX4T-2 vector using sense and antisense oligonucleotides corresponding to the amino acid sequence.
Bacterial protein expression
Recombinant GST-fused proteins were produced in E coli BL21 strain (Stratagene) and puri®ed with glutathioneSepharose beads (Amersham Biosciences). For N-terminal His 6 -tagged recombinant Aurora-B (DN) and histone H3.3, Aurora-B (DN) and histone H3.3 were subcloned into pQE30 (Qiagen), expressed in the bacterial strain M15 [pREP4] , and the fusion polypeptide was puri®ed by Ni 2+ -nitrilotriacetic acid chromatography (Qiagen). Histone H3.3 was puri®ed under denaturing conditions using 8M urea according to the manufacturer's protocol. All recombinant proteins were dialyzed with phosphate-buered saline. Coomassie Brilliant Blue R-250 staining of SDS-polyacrylamide gel electrophoresis gels determined the concentrations of recombinant proteins.
Transient transfection
COS-7 cells were maintained in DMEM supplemented with 10% FCS. COS-7 cells (3610 5 cells in 60 mm culture dishes) were transfected with mammalian expression vectors using DEAE-Dextran (Urano et al., 1996) .
Immunoprecipitation and GST-Aurora-B pull down assay HeLa cells or transfected COS cells in 60 mm dishes were lysed by rocking in 500 ml of RIPA buer (phosphatebuered saline with 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 1 mM phenylmethylsulfonyl¯uoride and 10 mg/ ml aprotinin) for 15 min at 48C. The lysates were clari®ed by centrifugation at 13 500 r.p.m. for 5 min, then immunoprecipitated with primary monoclonal antibody bound to protein G-Sepharose (Amersham Biosciences) at 48C for 75 min. For GST-Aurora-B pull down assay using COS cells, the clari®ed lysates were incubated with glutathione-Sepharose beads. The beads were washed ®ve times with 1 ml of PIRA buer and ®nally resuspended in 15 ml of 26SDS sample buer. The precipitated proteins were separated by SDS-polyacrylamide gel electrophoresis, then immunoblotted. Prior to immunocomplex kinase assays, glu-Aurora-B immunoprecipitates were additionally washed twice with kinase buer without dithiothreitol.
In vitro kinase assay
Reaction mixtures (30 ml) containing substrates, enzymes, 50 mM ATP, and 3 mCi of [g-32 P]ATP in kinase activity buer (20 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 0.5 mM dithiothreitol, 0.1 mM EDTA) were incubated for 20 min at 308C. The reaction products were separated by 12% SDSpolyacrylamide gel electrophoresis and visualized by Coomassie Brilliant Blue R-250 staining. The gels were dried, and 32 P was detected using a MacBAS-1500 imaging analyzer (Fuji Film).
Phosphatase treatment
Glu-tagged Aurora-B was transiently expressed in COS cells. Transfected cells were incubated for 30 min with 0.4 mM okadaic acid. Glu-Aurora-B immunoprecipitates were washed four times with RIPA buer and then washed two times with phosphatase buer (50 mM Tris-HCl, pH 7.5, 60 mM 2-mercaptoethanol, 0.1 mM MnCl 2 , 1 mM MgCl 2 , 0.1 mM EDTA). The immunocomplex was incubated for 30 min at 308C with indicated concentrations of PP1c puri®ed from rabbit skeletal muscle (Upstate Biotechnology) or PP2A holoenzyme (A-regulatory and catalytic subunits) puri®ed from human red blood cells (Upstate Biotechnology). The immunoprecipitates were washed ®ve times with RIPA buer and washed twice with kinase buer without dithiothreitol, and subsequently in vitro kinase assays were performed with 1 mM microcystin (Wako Chemicals).
